Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life
- PMID: 14580077
- DOI: 10.1017/s0033291703008213
Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life
Abstract
Background: Older adults are the main recipients of repeat prescriptions for benzodiazepine (BZD) hypnotics. BZDs can impair cognitive function and may not aid sleep when taken continuously for years. This study therefore aimed to determine if withdrawing from BZDs leads to changes in patients' cognitive function, quality of life, mood and sleep.
Method: One hundred and ninety-two long-term users of BZD hypnotics, aged > or = 65 years, were identified in 25 general practices. One hundred and four who wished to withdraw were randomly allocated to one of two groups under double-blind, placebo controlled conditions: group A's BZD dose was tapered from week 1 of the trial; group B were given their usual dose for 12 weeks and then it was tapered. An additional group (C) of 35 patients who did not wish to withdraw from BZDs participated as 'continuers'. All patients were assessed at 0, 12 and 24 weeks and 50% were reassessed at 52 weeks.
Results: Sixty per cent of patients had taken BZDs continuously for > 10 years; 27% for > 20 years. Of all patients beginning the trial, 80% had successfully withdrawn 6 months later. There was little difference between groups A and B, but these groups differed from continuers (C) in that the performance of the withdrawers on several cognitive/psychomotor tasks showed relative improvements at 24 or 52 weeks. Withdrawers and continuers did not differ in sleep or BZD withdrawal symptoms.
Conclusions: These results have clear implications for clinical practice. Withdrawal from BZDs produces some subtle cognitive advantages for older people, yet little in the way of withdrawal symptoms or emergent sleep difficulties. These findings also suggest that, taken long-term, BZDs do not aid sleep.
Comment in
-
Withdrawal of benzodiazepines in elderly long term users does not produce significant adverse effects in the short term.Evid Based Ment Health. 2004 May;7(2):46. doi: 10.1136/ebmh.7.2.46. Evid Based Ment Health. 2004. PMID: 15107342 No abstract available.
Similar articles
-
Withdrawal from long-term use of zopiclone, zolpidem and temazepam may improve perceived sleep and quality of life in older adults with primary insomnia.Basic Clin Pharmacol Toxicol. 2019 Mar;124(3):330-340. doi: 10.1111/bcpt.13144. Epub 2018 Dec 3. Basic Clin Pharmacol Toxicol. 2019. PMID: 30295409 Clinical Trial.
-
Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.Eur J Clin Pharmacol. 2014 Mar;70(3):319-29. doi: 10.1007/s00228-013-1613-6. Epub 2013 Dec 12. Eur J Clin Pharmacol. 2014. PMID: 24337417
-
Benzodiazepine harm: how can it be reduced?Br J Clin Pharmacol. 2014 Feb;77(2):295-301. doi: 10.1111/j.1365-2125.2012.04418.x. Br J Clin Pharmacol. 2014. PMID: 22882333 Free PMC article. Review.
-
Benzodiazepines revisited--will we ever learn?Addiction. 2011 Dec;106(12):2086-109. doi: 10.1111/j.1360-0443.2011.03563.x. Epub 2011 Oct 17. Addiction. 2011. PMID: 21714826 Review.
-
Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: a non-randomised clinical study in the elderly.Drugs Aging. 2007;24(12):1045-59. doi: 10.2165/00002512-200724120-00007. Drugs Aging. 2007. PMID: 18020536 Clinical Trial.
Cited by
-
Evaluation of the effectiveness of a joint general practitioner-pharmacist intervention on the implementation of benzodiazepine deprescribing in older adults (BESTOPH-MG trial): protocol for a cluster-randomized controlled trial.Front Med (Lausanne). 2023 Aug 25;10:1228883. doi: 10.3389/fmed.2023.1228883. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37711743 Free PMC article.
-
Examining Adult Patients' Success with Discontinuing Long-term Benzodiazepine Use: a Qualitative Study.J Gen Intern Med. 2024 Feb;39(2):247-254. doi: 10.1007/s11606-023-08385-z. Epub 2023 Aug 31. J Gen Intern Med. 2024. PMID: 37653209
-
Benzodiazepine use and risk of incident MCI and dementia in a community sample.Int Psychogeriatr. 2024 Feb;36(2):142-148. doi: 10.1017/S1041610223000455. Epub 2023 May 26. Int Psychogeriatr. 2024. PMID: 37231775
-
Deprescribing Strategies for Opioids and Benzodiazepines with Emphasis on Concurrent Use: A Scoping Review.J Clin Med. 2023 Feb 23;12(5):1788. doi: 10.3390/jcm12051788. J Clin Med. 2023. PMID: 36902574 Free PMC article. Review.
-
Evolution of benzodiazepine receptor agonist prescriptions in general practice: A registry-based study.Front Public Health. 2022 Sep 23;10:1014734. doi: 10.3389/fpubh.2022.1014734. eCollection 2022. Front Public Health. 2022. PMID: 36211642 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical